Avita Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Avita Medical
RCEL Stock  USD 4.21  0.05  1.20%   
Avita Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avita Medical's valuation are provided below:
Gross Profit
58.8 M
Profit Margin
(0.68)
Market Capitalization
127.4 M
Enterprise Value Revenue
2.0607
Revenue
71.6 M
There are over one hundred nineteen available fundamental signals for Avita Medical, which can be analyzed over time and compared to other ratios. We recommend to validate Avita Medical's prevailing fundamental drivers against the all of the trends between 2010 and 2026. Market Cap is expected to rise to about 182 M this year. Working Capital is expected to rise to about 3.1 M this year

Avita Medical Total Revenue

75.19 Million

Check Avita Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 5.3 M or Selling General Administrative of 28.7 M, as well as many indicators such as Price To Sales Ratio of 1.28, Dividend Yield of 0.0 or Days Sales Outstanding of 44.0. Avita financial statements analysis is a perfect complement when working with Avita Medical Valuation or Volatility modules.
  
Build AI portfolio with Avita Stock
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Avita Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets29.1 M56.4 M49.4 M
Slightly volatile
Total Current Liabilities65.8 M62.7 M13.4 M
Slightly volatile
Cash11.3 M10.2 M17.3 M
Slightly volatile
Non Current Assets Total21.9 M20.9 M7.1 M
Slightly volatile
Cash And Short Term Investments17.8 M18.2 M28.7 M
Slightly volatile
Net Receivables9.5 M9.1 M3.7 M
Slightly volatile
Common Stock Shares Outstanding29.3 M27.9 M15.1 M
Slightly volatile
Liabilities And Stockholders Equity59.2 M56.4 M43.4 M
Slightly volatile
Non Current Liabilities Total10.9 M10.4 M8.2 M
Slightly volatile
Total Liabilities76.7 M73 M20.5 M
Slightly volatile
Total Current Assets24.3 M35.5 M44.8 M
Slightly volatile
Inventory7.3 M6.9 M2.6 M
Slightly volatile
Other Current Assets1.1 M1.3 M1.6 M
Very volatile
Accounts Payable9.4 M9 M3 M
Slightly volatile
Property Plant And Equipment Net12.1 M11.5 M3.2 M
Slightly volatile
Common Stock Total Equity3.3 K3.5 K60.1 M
Slightly volatile
Property Plant And Equipment Gross17.5 M16.6 M4.3 M
Slightly volatile
Property Plant Equipment1.7 M2.4 M2 M
Very volatile
Net Invested Capital25 M26.3 M31.9 M
Slightly volatile
Capital Stock2.6 K2.7 K84.2 M
Slightly volatile

Avita Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.3 M461.4 K
Slightly volatile
Selling General Administrative28.7 M27.4 M14.5 M
Slightly volatile
Other Operating Expenses7.5 M7.9 M29.5 M
Slightly volatile
Total Revenue75.2 M71.6 M21.1 M
Slightly volatile
Gross Profit61.8 M58.8 M17.4 M
Slightly volatile
Selling And Marketing Expenses55.8 M53.1 M18.1 M
Slightly volatile
Cost Of Revenue13.4 M12.8 M3.7 M
Slightly volatile
Research Development21.9 M20.8 M10.1 M
Slightly volatile
Interest Income67.6 K43.4 K73.8 K
Slightly volatile
Reconciled Depreciation2.5 M2.3 M584.1 K
Slightly volatile

Avita Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow13.8 M14.1 M23.2 M
Very volatile
Depreciation2.1 M2 M624.9 K
Slightly volatile
Stock Based Compensation5.3 M9.5 M4.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.281.342328.8185
Slightly volatile
Days Sales Outstanding44.046.311897.9227
Slightly volatile
Invested Capital4.5 M7.4 M8 M
Slightly volatile
Average Payables102.7 K108.1 K436.9 K
Slightly volatile
Stock Based Compensation To Revenue0.130.13290.6079
Slightly volatile
Capex To Depreciation7.837.463.478
Slightly volatile
EV To Sales1.171.22925.8719
Slightly volatile
Inventory Turnover2.851.84722.6151
Slightly volatile
Days Of Inventory On Hand261198363
Slightly volatile
Payables Turnover1.741.661.4575
Pretty Stable
Sales General And Administrative To Revenue0.360.38232.7263
Slightly volatile
Average Inventory12.6 K13.3 K239.9 K
Slightly volatile
Research And Ddevelopement To Revenue0.280.2911.6013
Slightly volatile
Capex To Revenue0.180.170.101
Very volatile
Cash Per Share0.620.65272.14
Very volatile
Days Payables Outstanding286227375
Slightly volatile
Net Current Asset Value2.9 M2.2 M2.5 M
Very volatile
Income Quality0.90.6420.8828
Slightly volatile
Tangible Asset Value4.1 M2.4 M2.8 M
Slightly volatile
Intangibles To Total Assets0.09510.10010.0584
Slightly volatile
Current Ratio0.540.56625.8853
Very volatile
Receivables Turnover8.447.88145.0882
Slightly volatile
Capex Per Share0.340.320.0879
Slightly volatile
Average Receivables467.9 K238.2 K572.2 K
Slightly volatile
Revenue Per Share2.72.57031.1211
Slightly volatile
Debt To Assets0.05770.03790.0689
Slightly volatile
Graham Number77.1486.7994.7306
Slightly volatile
Operating Cycle232244456
Slightly volatile
Days Of Payables Outstanding286227375
Slightly volatile
Quick Ratio0.430.45575.5838
Very volatile
Net Income Per E B T1.561.00020.9961
Slightly volatile
Cash Ratio0.160.16343.8103
Pretty Stable
Days Of Inventory Outstanding261198363
Slightly volatile
Days Of Sales Outstanding44.046.311897.9227
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.71.070.9805
Slightly volatile
Fixed Asset Turnover5.96.211310.5638
Slightly volatile
Debt Ratio0.05770.03790.0689
Slightly volatile
Price Sales Ratio1.281.342328.8185
Slightly volatile
Asset Turnover1.331.26990.3856
Slightly volatile

Avita Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap182 M96.1 M242 M
Slightly volatile
Working Capital3.1 M2.3 M2.6 M
Pretty Stable
Enterprise Value107.3 M88 M220.3 M
Slightly volatile

Avita Fundamental Market Drivers

Forward Price Earnings4.8193
Cash And Short Term Investments18.2 M

Avita Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avita Medical Financial Statements

Avita Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Avita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue38 K36.1 K
Total Revenue71.6 M75.2 M
Cost Of Revenue12.8 M13.4 M
Stock Based Compensation To Revenue 0.13  0.13 
Sales General And Administrative To Revenue 0.38  0.36 
Research And Ddevelopement To Revenue 0.29  0.28 
Capex To Revenue 0.17  0.18 
Revenue Per Share 2.57  2.70 
Ebit Per Revenue 0.89  0.93 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
How To Invest In Avita
Details
Is Avita Stock a good investment?
Details
What is Avita Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. Anticipated expansion of Avita directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avita Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.81)
Revenue Per Share
2.57
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.39)
Return On Equity
(17.46)
Investors evaluate Avita Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Avita Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Avita Medical's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Avita Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avita Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Avita Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY